U.S. physician survey highlights impact and burden of Thyroid Eye Disease on patients’ quality of life

Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients’ quality of life.